miRNAs | Mechanisms | Functions | Tissues |
---|---|---|---|
miR-29a and miR-29b | inhibit CAV2, INSIG1, PIK3R1 | inhibit insulin signaling | liver |
miR-126 | inhibit IRS1 | inhibit insulin signaling | liver |
miR-223 | inhibit GLUT4 | inhibit glucose uptake | muscle |
miR-33a and miR-33b | inhibit IRS2,SIRT6,AMPKa1 | inhibit insulin signaling | liver |
miR-130a | inhibit GRB10 | promote insulin signaling | liver |
miR-204 | inhibit GLP1R | promote insulin signaling | pancreas |
miR-378 | inhibit p110a | inhibit insulin signaling | liver |
miR-93 | inhibit Sirt7,Tbx3 | inhibit insulin signaling | null mice |
miR-103 and miR-107 | inhibit caveolin-1 | inhibit insulin signaling | liver |
miR-143 | inhibit ORP8 | inhibit insulin signaling | liver |
Let7 | inhibit IGF1R,INSR,IRS2 | inhibit insulin signaling | muscle |
miR-375 | inhibit MTPN | reduce insulin secretion | pancreas |
miR-124a | inhibit MTPN,FOXA2,RAB27A | reduce insulin secretion | pancreas |
miR-9 | inhibit OC2,SIRT1 | reduce insulin secretion | pancreas |
miR-29a and miR-29b | inhibit MCT1 | reduce insulin secretion | pancreas |
miR-184 | inhibit AGO2 | increase insulin secretion | pancreas |
miR-122 | Â | liver injure and NAFLD | serum |
miR-223 | Â | atherosclerosis | plasma |
miR-126 | Â | type 2 diabetes | plasma |
let7e | Â | hypertension | plasma |
miR-486, miR-146b and miR-15b | Â | type 2 diabetes | serum |
miR-199-3p | Â | type 2 diabetes | plasma |
miR-424 | Keap1 and Nrf2 | type 2 diabetes | serum |
miR-146a | Â | type 2 diabetes | plasma |